Beigani (Brigatinib) 30mg/90mg*21's | Generic ALK Inhibitor Laos | GLT

Generic Information: Beigani (Laos)

Beigani is a Lao-manufactured generic of brigatinib, produced by Trans Continental Life Science & Pharmaceuticals (TLPH). It is offered in 30 mg and 90 mg strengths, each in a 21-tablet box. The 30 mg strength supports the 7-day lead-in dosing of the brigatinib regimen, while the 90 mg strength serves as the starting maintenance dose for patients who cannot escalate to 180 mg.

What Is Beigani Used For?

Beigani is used for the treatment of anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer. It is an oral monotherapy that keeps treatment simple and home-based, and it is prescribed after a genetic test confirms the ALK rearrangement. Patients who have progressed on crizotinib may also be candidates for this medicine.

How Does Beigani (Brigatinib) Work?

The active ingredient brigatinib is a next-generation ALK inhibitor that additionally targets ROS1, IGF-1R, and FLT-3. It shuts down the signaling that drives ALK-positive cancer cells and crosses the blood-brain barrier, which is why it is effective against brain metastases. The generic Beigani reproduces the same mechanism as the originator at a lower price.

Indications

Beigani is indicated for adults with ALK-positive, locally advanced or metastatic NSCLC. A confirmed ALK rearrangement is required before prescribing. The medicine is not indicated for ALK-negative tumors or for small-cell lung cancer.

Dosage

The standard schedule is 90 mg once daily for the first 7 days, increasing to 180 mg once daily if tolerated. The 30 mg and 90 mg strengths in this listing support the lead-in and reduced-dose phases. Take the tablet with or without food at the same time each day and swallow it whole. If a dose is missed, continue with the next scheduled dose rather than doubling up.

Side Effects

Typical side effects include diarrhea, rash, cough, hypertension, fatigue, nausea, muscle pain, and headache. Most are mild to moderate and respond to supportive care and temporary dose adjustment. Patients should report any new or worsening breathing difficulty promptly, as interstitial lung disease, although rare, requires permanent discontinuation.

Storage

Store Beigani below 30°C in a dry place, inside the original packaging, and away from children. There is no cold-chain requirement.

Why Choose the GLT?

For uninsured or under-insured patients, a Lao generic such as Beigani is a far more economical option than the originator brand, whose Western list price can be several times higher. GLT sources from verified manufacturers and provides the documentation needed for international delivery, so patients can continue therapy without exhausting their budget.

How to Order

To order Beigani through GLT, message us on WhatsApp at +86 15234153837 or write to [email protected]. Tell us the strength, quantity, and your country, and our team will confirm stock, sourcing origin, and delivery details. We serve hospitals, pharmacies, and individual patients alike.

FAQ

Is Beigani a generic of brigatinib? Yes. Beigani is a Lao-manufactured generic of brigatinib, produced by Trans Continental Life Science & Pharmaceuticals (TLPH).

What strengths does Beigani come in? Beigani is available in 30 mg and 90 mg tablets, each in a 21-tablet box, matching the lead-in and reduced-dose needs of the brigatinib schedule.

Where can I buy generic brigatinib? Generic brigatinib can be sourced through international suppliers such as GLT. Always verify the supplier and request proper documentation before purchasing.